Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

From soaring drug expenses in the Great Plains to rising supply costs in the West, regional disparities highlight the unique pressures facing hospital leaders. As labor shortages persist, supply ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

The cost of cancer drugs paid by Medicare has been soaring in recent years, yet these rising prices do not seem to reflect any improvements in patient survival or overall health. Between 2012 and ...

Nineteen companies, led by Pfizer, Johnson & Johnson, and UnitedHealth, accounted for 80% of payouts. Researchers suggest ...

Among the common goods that are made in China are many generic prescription drugs and pharmacists are worried that those ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.